The company lowered its full-year EPS guidance from a range of $5.62-$5.66 to $5.50-$5.54, citing a $157M charge and IPO dilution related to its MiniMed subsidiary. This downward revision creates immediate pressure on management to find cost efficiencies or improve operational performance to meet revised targets.
Filing excerpt
As a result of the foregoing factors related to MiniMed that are expected to have an impact in the fourth quarter of fiscal year 2026, on March 24, 2026, Medtronic announced that it now expects non-GAAP earnings per share (EPS) for fiscal year 2026 to be in the range of $5.50 to $5.54, a revision from the Q3 earnings call EPS guidance of $5.62 to $5.66.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
Regions named
sec-8kmarginPressureGet every 8-K signal for Medtronic and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medtronic this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/aea2f6ef-165b-4ca2-8d65-47becc7b2c74 returns this record as JSON. POST /v1/companies/enrich returns every signal for medtronic.com.
{
"signal_id": "aea2f6ef-165b-4ca2-8d65-47becc7b2c74",
"signal_type": "sec-8k",
"signal_subtype": "marginPressure",
"detected_at": "2026-03-31T08:16:23.329+00:00",
"company": {
"name": "Medtronic",
"domain": "medtronic.com"
},
"data": {
"detail": "The company lowered its full-year EPS guidance from a range of $5.62-$5.66 to $5.50-$5.54, citing a $157M charge and IPO dilution related to its MiniMed subsidiary. This downward revision creates immediate pressure on management to find cost efficiencies or improve operational performance to meet revised targets.",
"metrics": {
"pct": 2.1,
"timeframe": "current_quarter",
"pct_context": "Approximate percentage decrease in the midpoint of FY2026 EPS guidance."
},
"summary": "Medtronic cuts FY2026 EPS guidance by ~$0.12 due to MiniMed subsidiary costs.",
"excerpts": "As a result of the foregoing factors related to MiniMed that are expected to have an impact in the fourth quarter of fiscal year 2026, on March 24, 2026, Medtronic announced that it now expects non-GAAP earnings per share (EPS) for fiscal year 2026 to be in the range of $5.50 to $5.54, a revision from the Q3 earnings call EPS guidance of $5.62 to $5.66.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htm",
"filing_date": "2026-03-24",
"filing_year": 2026,
"fiscal_year_end": "03/24",
"sales_relevance": "Efficiency tools needed",
"signal_category": "financial",
"regions_mentioned": [
"U.S."
],
"vendors_mentioned": [
"Blackstone Life Sciences Advisors L.L.C."
]
}
}
curl https://signals.autobound.ai/v1/signals/aea2f6ef-165b-4ca2-8d65-47becc7b2c74 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"medtronic.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.